Marker Therapeutics, Inc. — Director's Dealing 2009

Mar 20, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TAPIMMUNE INC (TPIM)
CIK: 0001094038
Period of Report: 2009-03-11

Reporting Person: LINDSAY ALAN P (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-03-11	Purchase Warrants	$0.01	J	162000	Acquired	2009-10-15	Common Stock (162000)	Indirect

Footnotes

F1: Effective March 11, 2009, the Issuer ratified the issuance of these 162,000 share purchase warrants as partial consideration for a loan made to the Issuer pursuant to and in accordance with the terms of a promissory note.

F2: As previously reported on a Form 3 filed by the Reporting Person on July 3, 2007, the Reporting Person also holds options to purchase up to an aggregate of 880,000 shares of the Issuer's common stock at an exercise price of $0.25 per share, exercisable until June 8, 2017.